Abstract
Many cancer patients are treated with a combination of anticancer drugs. Here, we discuss the importance of drug scheduling and the need for studies that investigate the optimal timing of the various anticancer drugs. Positron emission tomography (PET) using radiolabeled anticancer drugs could be an important tool for those studies.
MeSH terms
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Agents / chemistry
-
Drug Administration Schedule
-
Humans
-
Isotope Labeling
-
Neoplasms / diagnosis
-
Neoplasms / drug therapy*
-
Positron-Emission Tomography
-
Radiopharmaceuticals / administration & dosage*
-
Radiopharmaceuticals / chemistry
Substances
-
Antineoplastic Agents
-
Radiopharmaceuticals